Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 6 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Bootstrap gate driver
Card reader device
Resistor and manufacturing method thereof
O-space imaging: highly efficient parallel imaging using complementary nonlinear encoding gradient fields and receive coil geometries
Integrated advance copper fuse combined with ESD/over-voltage/reverse polarity protection
Image forming apparatus
  Randomly Featured Patents
Method of determining features of events or processes having a dynamic evolution in space and/or time
Pressed powder pan cleaning machine
Insulated beverage receptacle
Oligonucleotide multiple reporter precursors
Articulated vehicle wheel tracking mechanism
Hand held unit for determining photometric data
Glass production sequencing
Process for the manufacture of 1-chloro-1,1-difluoroethane
Washing machine with control unit that implements spinning profile comprising a loosening step for forming shallow creases
Beam hardening correction for CT perfusion measurements